Robert Pilarski, MS, LGC, MSW, LSW, presented “Current Prostate Cancer Genetic Testing Capabilities and Considerations” for the Grand Rounds in Urology audience in January 2020.

How to cite: Pilarski, Robert. “Current Prostate Cancer Genetic Testing Capabilities and Considerations” December, 2020. Accessed Aug 2020. https://grandroundsinurology.com/current-prostate-cancer-genetic-testing-capabilities-and-considerations/

Current Prostate Cancer Genetic Testing Capabilities and Considerations – Summary:

Robert Pilarski, MS, LGC, MSW, LSW, a certified genetic counselor, reviews the range of options currently available for genetic screening for prostate cancer. He weighs the advantages and disadvantages of different options for genetic testing, suggests criteria for selecting a lab, and discusses controversies with direct-to-consumer genetic testing.

This educational activity is based on a series of lectures on genetic testing for prostate cancer from the 2019 Philadelphia Prostate Cancer Consensus Conference. Further activities from this conference include:

Germline Predisposition for Prostate Cancer Among African American and Other Minorities: What Do We Know?
Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness
Prostate Cancer Screening & Genetic Testing: The NCCN Perspective
A Urologist’s Perspective on Germline Testing
Integration of Germline Testing in Prostate Cancer Screening
Current NCCN Recommendations for Prostate Cancer Genetic Testing
The Expanding World of Germline Testing for Prostate Cancer: Genetic Counseling Perspective
The Expanding World of Germline Testing for Prostate Cancer: A Clinical Trials Perspective